Reason for request

Reassessment

Summary of opinion  

Unfavourable opinion for reimbursement in premedication before induction of anaesthesia in adults and children over the age of 6 months.


Clinical Benefit

Insufficient

The Committee deems that the clinical benefit of MIDAZOLAM VIATRIS (midazolam) 1 mg/ml and 5 mg/ml solutions for injection or rectal use are insufficient to justify public funding cover in premedication before induction of anaesthesia in adults and children over the age of 6 months in view of the available alternatives.


Clinical Added Value

Not applicable

Contact Us

Évaluation des médicaments